Polar Asset Management Partners Inc. 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 06:53 am Purchase | 2023-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | Polar Asset Management Partners Inc. | 19,084 6.100% | 15,644 (+454.77%) | Filing |
| 2023-02-09 6:29 pm Sale | 2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | Polar Asset Management Partners Inc. | 3,440 10.000% | -13,060 (-79.15%) | Filing |
| 2022-02-08 11:07 am Purchase | 2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | Polar Asset Management Partners Inc. | 16,500 8.610% | 16,500 (New Position) | Filing |